文献速递妇产影像儿科影像技术与安全

胎儿结构异常的分子尸检:多学科团队方法的诊断与临床效用

Molecular autopsy for fetal structural anomaly: diagnostic and clinical utility of multidisciplinary team approach.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-08-12

本研究回顾性评估2021年产前死亡伴结构异常病例经围产期病理遗传多学科团队(MDT)评估的临床效用,共讨论123例,84例建议遗传评估、64例接受,29例获得30个诊断,总体诊断率24%(29/123),接受遗传检测者诊断率45%(29/64);尸检在79%病例提供可指导临床的表型数据。作者认为基因组检测是尸检的临床有用补充而非替代,MDT有助于评估和规划随访。

要点

  • 产前死亡伴结构异常者经MDT评估后,接受遗传检测病例的诊断率为45%(29/64)。
  • 总体诊断率为24%(29/123),共29例获得30个诊断,来自26个无亲缘关系家庭。
  • 尸检在79%病例提供可指导临床的表型数据,基因组检测为补充而非替代。

核心结论

  • 基因组检测是产前死亡伴结构异常病例尸检的临床有用补充而非替代。
  • MDT方法有助于评估病例并规划适当随访。
  • 加速全基因组测序或 panel-agnostic 分析对异质性表现最为合适,此广泛方法可扩展产前表型知识并发现新疾病基因,应作为未来研究优先事项。

研究设计与样本

  • 回顾性服务评估,纳入2021年1月至12月期间所有伴结构异常且疑遗传病因、接受围产期MDT评估的围产期死亡病例。
  • 所有病例接受完整或部分尸检及至少染色体微阵列分析,共123例在2021年MDT会议上讨论。
  • 数据从患者病历中收集人口学特征、表型、基因型、MDT建议、诊断、结局及尸检分析和遗传检测数据的影响。

诊断标准与关键数值

  • 84例建议遗传评估,64例接受;根据指征和可及性申请一系列遗传检测。
  • 29例获得30个诊断,来自26个无亲缘关系家庭;总体诊断率24%(29/123),接受遗传检测的疑遗传诊断病例诊断率45%(29/64)。
  • 尸检在79%病例提供可指导临床的表型数据。

临床应用与阅片要点

  • 遗传诊断使准确的复发风险咨询和适当随访成为可能,包括对遗传病患者的产前检测和植入前诊断。
  • MDT评估产前死亡伴结构异常病例并建议适当的基因组评估,有助于评估病例和规划随访。
  • 加速全基因组测序或 panel-agnostic 分析对异质性表现最为合适。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: In the West Midlands regional genetics service, cases of perinatal death with a possible genetic diagnosis are evaluated by the perinatal pathology genetic multidisciplinary team (MDT). The MDT assesses autopsy findings and suggests appropriate genomic assessment. The objective of this retrospective service evaluation was to determine the clinical utility of the MDT in assessing perinatal deaths associated with structural anomaly. This is the first evaluation since the introduction of whole-genome and whole-exome sequencing in routine clinical care.

METHODS: This was a retrospective service evaluation including all cases of perinatal death with an associated structural anomaly and suspected genetic etiology that underwent perinatal MDT assessment between January and December 2021. All cases received a full or partial postmortem examination and at least a chromosomal microarray analysis. Demographic characteristics, phenotype, genotype, MDT recommendations, diagnoses, outcomes and impact of postmortem analysis and genetic testing data were collected from patient case notes.

RESULTS: Overall, 123 cases were discussed at the MDT meetings in 2021. Genetic evaluation was recommended in 84 cases and accepted in 64 cases. A range of genetic tests were requested according to indication and availability. Thirty diagnoses were made in 29 cases from 26 unrelated families. The diagnostic yield was 24% (29/123) in all cases or 45% (29/64) in cases with a suspected genetic diagnosis who underwent genetic testing. Postmortem examination provided clinically actionable phenotypic data in 79% of cases. A genetic diagnosis enabled accurate recurrence risk counseling and provision of appropriate follow-up, including prenatal testing and preimplantation diagnosis for patients with inherited conditions.

CONCLUSIONS: Genomic testing was a clinically useful addition to (but not a substitute for) postmortem examination in cases of perinatal death associated with structural anomaly. The MDT approach helped assess cases and plan appropriate follow-up. Expedited whole-genome sequencing or panel-agnostic analysis were most appropriate for heterogeneous presentations. This broad approach can also expand knowledge of prenatal phenotypes and detect novel disease genes, and should be a priority in future research. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Wall E, Petley E, Mone F, et al. Molecular autopsy for fetal structural anomaly: diagnostic and clinical utility of multidisciplinary team approach. Ultrasound Obstet Gynecol. 2024. PMID: 38517166. doi:10.1002/uog.27647

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。